Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Roman Kischel's Biography



Roman Kischel, Principal Scientist, Amgen Research

Roman Kischel is Principal Scientist at Amgen Research (Munich) GmbH, Germany. Roman leads a group developing novel BiTE antibodies specific for different tumor target antigens. Roman has been with Amgen and before the acquisition by Amgen with Micromet for 12 years, working mainly on design and characterization of BiTE antibodies. Previously Roman worked at the Institut für Immunologie at the Ludwig-Maximilians-Universität in Munich. Roman received his M.D. from the Ludwig-Maximilians-Universität.

Roman Kischel Image

Targeting Cancer with BiTE® Antibody Constructs

Tuesday, 7 March 2017 at 12:15

Add to Calendar ▼2017-03-07 12:15:002017-03-07 13:15:00Europe/LondonTargeting Cancer with BiTE® Antibody ConstructsSELECTBIOenquiries@selectbiosciences.com

The presentation will demonstrate the structure and mode of action of BiTE® antibody constructs. Clinical and preclinical data for different BiTE® antibody constructs will be discussed.


Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com